Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...

Merck & Co took a hit on May 14, 2025, as Citigroup downgraded its rating from "Buy" to "Neutral" and slashed its price ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...